Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 69

Sort by

Sort Order Select

Journal Articles

Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma

Blood (2018) 132 (23): 2456–2464.

https://doi.org/10.1182/blood-2018-06-858613

Published: 2018

Includes: Supplemental data

Journal Articles

A Novel Evolutionary Pattern Revealed Using Deep Sequencing of Immunoglobulin Loci at Diagnosis and over the Course of Treatment in Multiple Myeloma Patients

Nikhil C. Munshi, MD, Joaquin Martinez-Lopez, Victoria Carlton, PhD, Stephanie Minvielle, Yu-Tzu Tai, PhD, Mariateresa Fulciniti, PhD, Mehmet K. Samur, PhD, Paul G. Richardson, MD, Michel Attal, Philippe Moreau, Florence Magrangeas, Kenneth C. Anderson, MD, Malek Faham, MD PhD, Herve Avet-Loiseau, MD PhD

Blood (2016) 128 (22): 238.

https://doi.org/10.1182/blood.V128.22.238.238

Published: 2016

Journal Articles

Antigen Presentation Profiling Reveals T-Cell Recognition of Lymphoma Immunoglobulin Neoantigens

Blood (2016) 128 (22): 915.

https://doi.org/10.1182/blood.V128.22.915.915

Published: 2016

Journal Articles

Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk Following Autologous Hematopoietic Cell Transplantation

Gabriel N. Mannis, MD, Thomas G. Martin, III, MD, Lloyd E. Damon, MD, Charalambos Andreadis, MD MSCE, Rebecca L. Olin, MD MSCE, Katie Kong, Malek Faham, MD PhD, Weiyun Z. Ai, MD PhD, Karin ML Gaensler, MD, Peter H. Sayre, MD PhD, Jeffrey L. Wolf, MD PhD, Aaron C. Logan, MD PhD

Blood (2015) 126 (23): 1420.

https://doi.org/10.1182/blood.V126.23.1420.1420

Published: 2015

Journal Articles

Quantitative Assessment of Circulating Clonal IG-VDJ Sequences in Plasma of Follicular Lymphoma at Diagnosis Is Highly Predictive of Progression Free Survival (PFS)

Clémentine Sarkozy, MD, Sarah Huet, PharmD, PhD, Victoria Carlton, Alain Delmer, MD PhD, Fabrice Jardin, Marie-Helene Delfau-Larue, MD PhD, Malek Faham, Gilles Salles, MD PhD

Blood (2015) 126 (23): 2675.

https://doi.org/10.1182/blood.V126.23.2675.2675

Published: 2015

Journal Articles

Pre-Transplant R-Bendamustine Induces High Rates of Minimial Residual Disease in MCL Patients: Updated Results of S1106: US Intergroup Study of a Randomized Phase II Trial of R-HCVAD Vs. R-Bendamustine Followed By Autologous Stem Cell Transplants for Patients with Mantle Cell Lymphoma

Blood (2015) 126 (23): 518.

https://doi.org/10.1182/blood.V126.23.518.518

Published: 2015

Journal Articles

Assessment of Central Nervous System Involvement in Pediatric Acute Lymphoblastic Leukemia Patients Using Next-Generation Sequencing Method

John K Choi, Sima Jeha, Jianbiao Zheng, Victoria Carlton, Malek Faham, MD PhD, Ching-Hon Pui, MD

Blood (2015) 126 (23): 4981.

https://doi.org/10.1182/blood.V126.23.4981.4981

Published: 2015

Journal Articles

Molecular Remission One Year Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia Predicts Relapse-Free and Overall Survival: A Multi-Institutional Landmark Analysis

Aaron C. Logan, MDPhD, Alex F. Herrera, MD, Christine E. Ryan, Andrew R. Rezvani, MD, Katherine A. Kong, PhD, Malek Faham, MD PhD, Gheath Alatrash, DO, PhD, Jeffrey J. Molldrem, MD, Rachel L. Sargent, MD, Edwin P. Alyea, MD, Vincent T. Ho, MD, Jennifer R. Brown, MD PhD, Jerome Ritz, MD, David B. Miklos, MD PhD

Blood (2015) 126 (23): 4340.

https://doi.org/10.1182/blood.V126.23.4340.4340

Published: 2015

Journal Articles

Sequencing-Based Detection of Circulating Tumor DNA in the Autologous Stem Cell Grafts of Patients with Diffuse Large B-Cell Lymphoma Undergoing Hematopoietic Stem Cell Transplantation

Alex F. Herrera, MD, Reid W. Merryman, MD, Katherine A. Kong, PhD, Heather Sun, Jennifer R. Brown, MD PhD, David C. Fisher, MD, Matthew S. Davids, MD, Eric D. Jacobsen, MD, Caron A. Jacobson, MD, Haesook T. Kim, PhD, Ann S. LaCasce, MD, German A. Pihan, MD, Aliyah R Sohani, MD, Scott J. Rodig, MD, PhD, Arnold S. Freedman, MD, Jerome Ritz, MD, Malek Faham, MD PhD, Philippe Armand, MD PhD

Blood (2015) 126 (23): 3156.

https://doi.org/10.1182/blood.V126.23.3156.3156

Published: 2015

Journal Articles

Deep Igh Sequencing Identifies an Ongoing Somatic Hypermutation Process with Complex and Evolving Clonal Architecture in Myeloma

Nikhil C. Munshi, MD, Stephane Minvielle, Yu-Tzu Tai, PhD, Mariateresa Fulciniti, Mehmet K Samur, PhD, Paul G. Richardson, MD, Michel Attal, Philippe Moreau, Florence Magrangeas, Kenneth C Anderson, Malek Faham, MD PhD, Herve Avet-Loiseau

Blood (2015) 126 (23): 21.

https://doi.org/10.1182/blood.V126.23.21.21

Published: 2015

Journal Articles

Prognostic Value of Sequencing-Based Minimal Residual Disease Detection in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation

Hiroyuki Takamatsu, Ryoichi Murata, MD, Jianbiao Zheng, Martin Moorhead, Naoki Takezako, Shigeki Ito, MD PhD, Toshihiro Miyamoto, MD PhD, Kenji Yokoyama, Kosei Matsue, MD PhD, Tsutomu Sato, MD PhD, Toshiro Kurokawa, MD PhD, Hideo Yagi, Yasushi Terasaki, MD PhD, Kinya Ohata, MD PhD, Takashi Yoshida, MD PhD, Malek Faham, MD PhD, Shinji Nakao, MD PhD

Blood (2015) 126 (23): 1788.

https://doi.org/10.1182/blood.V126.23.1788.1788

Published: 2015

Journal Articles

Phase I/II Clinical Trial of CpG-Activated Whole Cell Vaccine in Mantle Cell Lymphoma (MCL): Results in Safety and Efficacy from Planned Interim Analysis

Blood (2015) 126 (23): 1536.

https://doi.org/10.1182/blood.V126.23.1536.1536

Published: 2015

Journal Articles

Impact of Minimal Residual Disease in High and Standard Risk Multiple Myeloma

Blood (2015) 126 (23): 2979.

https://doi.org/10.1182/blood.V126.23.2979.2979

Published: 2015

Journal Articles

Evaluation of Minimal Residual Disease (MRD) By Next Generation Sequencing (NGS) Is Highly Predictive of Progression Free Survival in the IFM/DFCI 2009 Trial

Blood (2015) 126 (23): 191.

https://doi.org/10.1182/blood.V126.23.191.191

Published: 2015

Journal Articles

A Comparison of Minimal Residual Disease Detection Among ASO-PCR, Dd-PCR and Deep-Sequencing in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation

Rachel K Wee, Hiroyuki Takamatsu, MD PhD, Ryoichi Murata, MD, Jianbiao Zheng, PhD, Martin Moorhead, PhD, Naoki Takezako, MD PhD, Shigeki Ito, MD PhD, Toshihiro Miyamoto, MD PhD, Kenji Yokoyama, MD PhD, Kosei Matsue, MD PhD, Tsutomu Sato, MD PhD, Toshiro Kurokawa, MD PhD, Hideo Yagi, MD PhD, Yasushi Terasaki, MD PhD, Kinya Ohata, MD PhD, Takashi Yoshida, MD PhD, Malek Faham, MD PhD, Shinji Nakao, MD PhD

Blood (2015) 126 (23): 1782.

https://doi.org/10.1182/blood.V126.23.1782.1782

Published: 2015

Journal Articles

Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing

Blood (2015) 125 (24): 3679–3687.

https://doi.org/10.1182/blood-2015-03-635169

Published: 2015

Includes: Supplemental data

Journal Articles

Next-Generation Sequencing Reveals Clonal Evolution at the Immunoglobulin Loci in Chronic Lymphocytic Leukemia

Jennifer R. Brown, Stacey M. Fernandes, Siddha Kasar, Kevin Hoang, Martin Moorhead, PhD, Victoria Carlton, Malek Faham, David B. Miklos, Aaron C. Logan

Blood (2014) 124 (21): 3302.

https://doi.org/10.1182/blood.V124.21.3302.3302

Published: 2014

Journal Articles

Minimal Residual Disease Detection Using High-Throughput Sequencing Predicts Clinical Outcome in Patients with Pediatric B-Lineage Acute Lymphoblastic Leukemia

Marian Harris, Donna S. Neuberg, ScD, Jianbiao Zheng, Malek Faham, Stephen E. Sallan, Lewis B. Silverman

Blood (2014) 124 (21): 2391.

https://doi.org/10.1182/blood.V124.21.2391.2391

Published: 2014

Journal Articles

Assessment of Central Nervous System Involvement in Pediatric Acute Lymphoblastic Leukemia Patients Using Next-Generation Sequencing Method

John K. Choi, MD, Sima Jeha, MD, Li Weng, Victoria Carlton, Malek Faham, Ching-Hon Pui, MD

Blood (2014) 124 (21): 5343.

https://doi.org/10.1182/blood.V124.21.5343.5343

Published: 2014

Journal Articles

Chronic Lymphocytic Leukemia Patients Harbor Very Low Frequency Stereotypic Immunoglobulin CDR3 Sequences

Jennifer R. Brown, Mark Klinger, Kieran Hervold, Stacey M. Fernandes, Kevin Hoang, Malek Faham, Yasuhiro Oki, Jeffrey L. Wolf, Joaquin Martinez-Lopez

Blood (2014) 124 (21): 5635.

https://doi.org/10.1182/blood.V124.21.5635.5635

Published: 2014

NARROW

Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma

A Novel Evolutionary Pattern Revealed Using Deep Sequencing of Immunoglobulin Loci at Diagnosis and over the Course of Treatment in Multiple Myeloma Patients

Antigen Presentation Profiling Reveals T-Cell Recognition of Lymphoma Immunoglobulin Neoantigens

Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk Following Autologous Hematopoietic Cell Transplantation

Quantitative Assessment of Circulating Clonal IG-VDJ Sequences in Plasma of Follicular Lymphoma at Diagnosis Is Highly Predictive of Progression Free Survival (PFS)

Pre-Transplant R-Bendamustine Induces High Rates of Minimial Residual Disease in MCL Patients: Updated Results of S1106: US Intergroup Study of a Randomized Phase II Trial of R-HCVAD Vs. R-Bendamustine Followed By Autologous Stem Cell Transplants for Patients with Mantle Cell Lymphoma

Assessment of Central Nervous System Involvement in Pediatric Acute Lymphoblastic Leukemia Patients Using Next-Generation Sequencing Method

Molecular Remission One Year Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia Predicts Relapse-Free and Overall Survival: A Multi-Institutional Landmark Analysis

Sequencing-Based Detection of Circulating Tumor DNA in the Autologous Stem Cell Grafts of Patients with Diffuse Large B-Cell Lymphoma Undergoing Hematopoietic Stem Cell Transplantation

Deep Igh Sequencing Identifies an Ongoing Somatic Hypermutation Process with Complex and Evolving Clonal Architecture in Myeloma

Prognostic Value of Sequencing-Based Minimal Residual Disease Detection in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation

Phase I/II Clinical Trial of CpG-Activated Whole Cell Vaccine in Mantle Cell Lymphoma (MCL): Results in Safety and Efficacy from Planned Interim Analysis

Impact of Minimal Residual Disease in High and Standard Risk Multiple Myeloma

Evaluation of Minimal Residual Disease (MRD) By Next Generation Sequencing (NGS) Is Highly Predictive of Progression Free Survival in the IFM/DFCI 2009 Trial

A Comparison of Minimal Residual Disease Detection Among ASO-PCR, Dd-PCR and Deep-Sequencing in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation

Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing

Next-Generation Sequencing Reveals Clonal Evolution at the Immunoglobulin Loci in Chronic Lymphocytic Leukemia

Minimal Residual Disease Detection Using High-Throughput Sequencing Predicts Clinical Outcome in Patients with Pediatric B-Lineage Acute Lymphoblastic Leukemia

Assessment of Central Nervous System Involvement in Pediatric Acute Lymphoblastic Leukemia Patients Using Next-Generation Sequencing Method

Chronic Lymphocytic Leukemia Patients Harbor Very Low Frequency Stereotypic Immunoglobulin CDR3 Sequences

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only